Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fatty acid synthase: a druggable driver of breast cancer brain metastasis
Javier A. Menéndez, Ruth Lupu
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 427-444
Closed Access | Times Cited: 20

Showing 20 citing articles:

Cancer metabolism and carcinogenesis
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 32
The implications of FASN in immune cell biology and related diseases
Y Xiao, Yonghong Yang, Huabao Xiong, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer
Jia Wang, Wen‐Feng Zhang, Cun Liu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1884-1904
Open Access | Times Cited: 9
The lipid droplet in cancer: From being a tumor‐supporting hallmark to clinical therapy
Yingfang Cui, Shuli Man, Jiejing Tao, et al.
Acta Physiologica (2024) Vol. 240, Iss. 3
Closed Access | Times Cited: 7
Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells
Emily M. Esquea, Lorela Ciraku, Riley G. Young, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
FASN inhibition shows the potential for enhancing radiotherapy outcomes by targeting glycolysis, AKT, and ERK pathways in breast cancer
Ching-I Chen, Deng-Yu Kuo, Hui-Yen Chuang
International Journal of Radiation Biology (2025), pp. 1-12
Open Access
Endoplasmic Reticulum Stress and Its Role in Metabolic Reprogramming of Cancer
Salvatore Zarrella, Maria Rosaria Miranda, Verdiana Covelli, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 221-221
Open Access
Harnessing the Role of ESR1 in Breast Cancer: Correlation with microRNA, lncRNA, and Methylation
Shengping Yang, Claudio Manna, Pulak R. Manna
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3101-3101
Open Access
Stearate‐derived very long‐chain fatty acids are indispensable to tumor growth
Qiaoyun Chu, Ping Liu, Yihan Song, et al.
The EMBO Journal (2022) Vol. 42, Iss. 2
Open Access | Times Cited: 14
Prognostic and clinicopathological significance of fatty acid synthase in breast cancer: A systematic review and meta-analysis
Binyan Liu, Peng Qi, Ya‐Wen Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Lipid metabolism in malignant tumor brain metastasis: reprogramming and therapeutic potential
Yanjie Cheng, Fan Fan, Zhong Zhang, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 9, pp. 861-878
Closed Access | Times Cited: 8
Theoretical Framework and Emerging Challenges of Lipid Metabolism in Cancer
Qiuying Gu, Yuan Wang, Ping Yi, et al.
Seminars in Cancer Biology (2024)
Open Access | Times Cited: 2
Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology
Javier A. Menéndez, Elisabet Cuyàs, José Antonio Encinar, et al.
Molecular Oncology (2023) Vol. 18, Iss. 3, pp. 479-516
Open Access | Times Cited: 6
Identification of Lipid Droplet-Associated Genes in Breast Cancer Patients
Şenol Doğan, Jenny Leopold, Daniel T. Hoffmann, et al.
Deleted Journal (2024) Vol. 1, Iss. 1, pp. 52-74
Open Access | Times Cited: 1
Metastatic brain tumors: from development to cutting‐edge treatment
Guilong Tanzhu, Liu Chen, Jiaoyang Ning, et al.
MedComm (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 1
AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models
Emma Polonio‐Alcalá, Rut Porta, Santiago Ruiz‐Martínez, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113942-113942
Open Access | Times Cited: 6
Hypomethylated gene RAC3 induces cell proliferation and invasion by increasing FASN expression in endometrial cancer
Cai Meijuan, Fang Liu, Min Fang, et al.
The International Journal of Biochemistry & Cell Biology (2022) Vol. 150, pp. 106274-106274
Closed Access | Times Cited: 5
Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity
Elisabet Cuyàs, Stefano Pedarra, Sara Verdura, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN
Shijiang Wang, Jiangbo Nie, Huinan Jiang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access
Fatty Acid Synthase-Derived Lipid Stores Support Breast Cancer Metastasis
Chaylen Andolino, Eylem Kulkoyluoglu‐Cotul, Zilin Xianyu, et al.
Research Square (Research Square) (2024)
Open Access
Identification of lipid droplet-associated genes in breast cancer patients
Şenol Doğan, Jenny Leopold, Daniel T. Hoffmann, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas
Paul M. Bingham, Zuzana Zachar
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14365-14365
Open Access
Page 1

Scroll to top